Interactive Grand Rounds including orbital pseudotumor, dupilumab keratitis, conjunctival papillomas, ocular surface squamous neoplasias, ocular rosacea & non-glaucomatous optic neuropathies
Date: 17/05/2023 (AEST)
Venue: Eyes Wide Bay, 6 Bayswater Drive, Urraween, QLD, 4655
Provider: Eyes Wide Bay
Contact: Kerryn Drew, [E] raesandford@hotmail.com, [P] 07 4194 2352
Learning Objectives
- Describe the differential diagnoses for orbital pseudotumour, as well as the presenting signs and symptoms, workup, and management
- List the PBS conditions approved for treatment with Vabysmo, and understand its potential benefits over other intravitreal drugs
- List the conditions dupilumab is approved for, and also the ocular side effects. Know which side effects may warrant cessation of treatment
- Describe common characteristics of sessile and pedunculated papilloma, the association of UV and human papilloma virus, and when treatment may be required
- List key features when examining an ocular surface tumour to assist in diagnosing and also prioritising the differential diagnosis
- List which of the types of OSSN have metastatic potential, and the management approach to these
- Describe the signs and symptoms of ocular rosacea, it’s complications and management
- List causes of non-glaucomatous optic neuropathy, and describe how to differentiate these using history, work-up and ancillary testing
Max CPD hours awarded: 3.5
Session Information
| Name |
|---|
| Grand Rounds |
| Clinical? |
| Yes |
| Interactive? |
| Yes |
| Therapeutic? |
| Yes |
| Duration of CPD Session/Module |
| 2.5 |
| Duration of CPD Session/Module inclusive of Assessment Component |
| 3.5 |